Multiple Myeloma

Still Revving Up With Revlimid
Motley Fool
Sat, 02/9/13 - 10:49 am
Revlimid
myelodysplastic syndrome
Multiple Myeloma
Celgene
FDA approves generic version of cancer drug Doxil
Reuters
Tue, 02/5/13 - 10:27 am
FDA
generics
Doxil
Sun Pharma
JNJ
ovarian cancer
Multiple Myeloma
Watson challenges patent on cancer drug Velcade
Yahoo/AP
Fri, 12/28/12 - 11:29 am
Watson Pharmaceuticals
Velcade
Millennium
Multiple Myeloma
Celgene Investors: What to Watch
Motley Fool
Sun, 12/16/12 - 10:19 am
Celgene
pomalidomide
Multiple Myeloma
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Celgene's Momentum Continues
Motley Fool
Wed, 12/12/12 - 08:06 am
Celgene
pomalidomide
Multiple Myeloma
Celgene’s Pomalidomide Helps in Myeloma After Others Fail
Bloomberg
Tue, 12/11/12 - 10:22 am
Celgene
pomalidomide
ONYX Pharmaceuticals
Multiple Myeloma
Ligand Pharmaceuticals confirms FDA accelerated approval of Kyprolis
The Fly on the Wall
Sat, 07/21/12 - 11:39 am
Ligand Pharmaceuticals
Kyprolis
Multiple Myeloma
Onyx Wins U.S. FDA Approval For Blood Cancer Treatment
Bloomberg
Sat, 07/21/12 - 11:27 am
ONYX Pharmaceuticals
Kyprolis
Multiple Myeloma
Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma
Pharmabiz
Sat, 06/30/12 - 04:35 pm
MLN9708
Multiple Myeloma
Millennium
Celgene down 13% after it pulls Revlimid filing
Marketwatch
Thu, 06/21/12 - 08:48 am
Celgene
Revlimid
Multiple Myeloma
Europe
FDA panel unanimously backs Onyx cancer drug
Yahoo/AP
Thu, 06/21/12 - 07:46 am
advisory panel
FDA
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
Onyx Pharma: FDA Panel Live Blog
TheStreet.com
Wed, 06/20/12 - 12:50 pm
ONYX Pharmaceuticals
FDA
advisory panels
Multiple Myeloma
Carfilzomib
Onyx’s Cancer Drug’s Risk May Outweigh Benefit, FDA Says
Bloomberg
Mon, 06/18/12 - 11:04 am
FDA
Onyx
Kyprolis
Multiple Myeloma
Pre-Clinical Data Demonstrates Promising Potential of MannKind’s IRE1α Inhibitor to Treat Multiple Myeloma
Yahoo
Thu, 05/31/12 - 06:26 pm
MannKind
IRE1α inhibitor
MKC-3946
Multiple Myeloma
Biotech Hot Potato: Perifosine
Motley Fool
Wed, 05/9/12 - 09:01 am
perifosine
Aeterna Zentaris
Takeda
JNJ
Keryx
Multiple Myeloma
Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Pharmalive
Sat, 04/28/12 - 12:50 pm
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
AEterna, Keryx soar on study speculation
Marketwatch
Mon, 03/5/12 - 06:16 pm
Keryx
Aeterna Zentaris
perifosine
colorectal cancer
Multiple Myeloma
Onyx' Cancer Drug on Right Track
Yahoo/Zacks.com
Wed, 11/30/11 - 10:37 am
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
Onyx Pharma submits NDA for carfilzomib in relapsed and refractory multiple myeloma
Pharmabiz
Sun, 10/2/11 - 12:35 pm
ONYX Pharmaceuticals
Carfilzomib
proteasome inhibitors
Multiple Myeloma

Pages